Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BBLG stock hub

Bone Biologics Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BBLGis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.4M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

BBLG

In the news

Latest news · BBLG

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-70.2

P25 -106.6P50 -46.9P75 -3.1

ROIC-45.6

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BBLG market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

164

Groups with data

Currency

USD

Showing 164 of 164 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001419554
Company name	Bone Biologics Corporation
Country	United States
Country code	US
Cusip	098070600
Employees	2
Employees Change	0%
Employees Change Percent	0
Enterprise value	$-3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US0980706008
Last refreshed	2026-05-10
Market cap	$2.4M
Market cap category	Nano-Cap
Price	$1.32
Price currency	USD
Sector	Healthcare
Sic	3842
Symbol	BBLG
Website	https://www.bonebiologics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-131.69%
FCF yield	-113.99%
P/B ratio	0.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-3.1M
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Profit Per Employee	$-1.6M
ROA	-41.87
ROCE	-60.16
ROE	-70.17
ROIC	-45.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-69.03%
Cagr1y	-67.12%
Cagr3y	-83.13%
Cagr5y	-86.28%
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$5.8M
Cash	$5.3M
Current Assets	$5.8M
Current Liabilities	$418,587
Equity	$5.4M
Liabilities	$418,587
Long Term Assets	$0
Long Term Liabilities	$0
Net Cash	$5.3M
Net Cash By Market Cap	$226
Net Cash Growth	60.42%
Net Debt Equity	$-0.99
Tangible Book Value	$5.4M
Tangible Book Value Per Share	$3
WACC	7.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	13.85
Net Working Capital	$43,226
Quick ratio	12.77
Working Capital	$5.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-364.45%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-67.09%
200-day SMA	1.8
3Y total return	-99.52%
50-day SMA	1.25
50-day SMA vs 200-day SMA	50under200
5Y total return	-100%
All Time High	212,399.8
All Time High Change	-100%
All Time High Date	2017-08-10
All Time Low	1.05
All Time Low Change	25.24%
All Time Low Date	2026-03-30
ATR	0.06
Beta	0.53
Beta1y	0.4
Beta2y	0.73
Ch YTD	-9.31
High	1.34
High52	6.75
High52 Date	2025-06-23
High52ch	-80.52%
Low	1.29
Low52	1.05
Low52 Date	2026-03-30
Low52ch	25.24%
Ma50ch	4.86%
Price vs 200-day SMA	-26.86%
RSI	51.64
RSI Monthly	39.6
RSI Weekly	39.66
Sharpe ratio	-0.82x
Sortino ratio	-1.14
Total Return	-364.45%
Tr YTD	-9.31
Tr1m	6.48%
Tr1w	0.12%
Tr3m	-6.07%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.54
Operating Income	$-3.2M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,794,585%
Float Percent	99.96%
Shares Insiders	0.04%
Shares Institutions	3.28%
Shares Out	1,795,260
Shares Qo Q	0.39%
Shares Yo Y	364.45%
Short Float	0.4%
Short Ratio	0.62
Short Shares	0.4

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-2.9M
Average Volume	9,148.3x
Bv Per Share	3
Ch10y	-100
Ch1m	6.48
Ch1w	0.15
Ch1y	-67.09
Ch3m	-6.07
Ch3y	-99.52
Ch5y	-100
Ch6m	-24.86
Change	1.94%
Change From Open	1.78
Close	1.29
Days Gap	0.16
Dollar Volume	10,353.3
Earnings Date	2026-05-13
Earnings Time	amc
EBIT	$-3.2M
EPS	$-2.65
F Score	2
FCF	$-2.7M
FCF EV Yield	90.5x
FCF Per Share	$-1.5
Financing CF	4,700,341
Fiscal Year End	December
Founded	2,004
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-02
Last Report Date	2025-12-31
Last Split Date	2025-06-10
Last Split Type	Reverse
Last10k Filing Date	2026-03-02
Ma150	1.61
Ma150ch	-18.27%
Ma20	1.33
Ma20ch	-1.13%
Net CF	2,009,191
Next Earnings Date	2026-05-22
Open	1.29
Optionable	No
Position In Range	47.92
Post Close	1.32
Postmarket Change Percent	1.14
Postmarket Price	$1.33
Price Date	2026-05-08
Ptbv Ratio	0.44
Relative Volume	0.86x
Share Based Comp	256,358
Tr6m	-24.86%
Us State	Massachusetts
Volume	7,873.2

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BBLG pay a dividend?

Capital-return profile for this ticker.

Performance

BBLG stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BBLG?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.3%

Float: +100.0% of shares outstanding

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BBLG momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.6

Neutral momentum band

Price vs 200-day MA

-26.9%

50/200-day relationship not available

Beta (5Y)

0.53

Less volatile than the market

Sharpe ratio

-0.82

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BBLG

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BBLG stock rating?

Bone Biologics Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BBLG analysis?

The full report lives at /stocks/BBLG/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BBLG?

The latest report frames BBLG around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BBLG page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.